Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-25-000118
Filing Date
2025-06-25
Accepted
2025-06-25 17:09:53
Documents
1
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750885786.html 4  
1 FORM 4 wk-form4_1750885786.xml 4 8309
  Complete submission text file 0001651308-25-000118.txt   10007
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address
Wang Lai (Reporting) CIK: 0001852291 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 251074436